Publications
-
Antibody-Dependent Cell-Mediated Virus Inhibition Antibody Activity Does Not Correlate With Risk of HIV-1 Superinfection.
Forthal DN,
Landucci G, Chohan B, Richardson BA, McClelland RS, Jaoko W, Blish C, Overbaugh J.
J Acquir Immune Defic Syndr.
2013;
63
(1):
31-33
-
Cellular immune responses and susceptibility to HIV-1 superinfection: a case-control study.
Blish CA,
Dogan OC, Jaoko W, McClelland RS, Mandaliya K, Odem-Davis KS, Richardsonb BA, Overbaugh J.
AIDS.
2012;
26
(5):
643-6
-
Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation.
Blish CA,
McClelland RS, Richardson BA, Jaoko W, Mandaliya K, Baeten JM, Overbaugh J.
J Acquir Immune Defic Syndr.
2012;
61
(4):
436-40
-
HIV-1 transmission goes retro (steps back).
Blish CA,
J Infect Dis.
2012;
206
(9):
1336-8
-
Measurements of immune responses for establishing correlates of vaccine protection against HIV.
Burgers WA,
Manrique A, Masopust D, McKinnon LR, Reynolds MR, Rolland M, Blish C, Chege GK, Curran R, Fischer W, Herrera C, Sather DN.
AIDS Res Hum Retroviruses.
2012;
28
(7):
641-8
-
The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life.
Slyker JA,
Lohman-Payne B, John-Stewart GC, Dong T, Mbori-Ngacha D, Tapia K, Atzberger A, Taylor S, Rowland-Jones SL, Blish CA.
Front Immunol.
2012:
3
399
-
Hormonal contraception and HIV-1 transmission.
Blish CA,
Baeten JM.
Am J Reprod Immunol.
2011;
65
(3):
302-7
-
The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection.
Lynch JB,
Nduati R, Blish CA, Richardson BA, Mabuka JM, Jalalian-Lechak Z, John-Stewart G, Overbaugh J.
J Virol.
2011;
85
(11):
5252-61
-
The role of amino acid changes in the human immunodeficiency virus type 1 transmembrane domain in antibody binding and neutralization.
Lovelace E,
Xu H, Blish CA, Strong R, Overbaugh J.
Virology.
2011;
421
(2):
235-44
-
Changes in plasma cytokines after treatment of ascaris lumbricoides infection in individuals with HIV-1 infection.
Blish CA,
Sangaré L, Herrin BR, Richardson BA, John-Stewart G, Walson JL.
J Infect Dis.
2010;
201
(12):
1816-21
-
Comparative immunogenicity of subtype a Human Immunodeficiency Virus type 1 envelope exhibiting differential exposure of conserved neutralization epitopes.
Blish CA,
Sather DN, Sellhorn G, Stamatatos L, Sun Y, Srivastava I, Barnett SW, Cleveland B, Overbaugh J, Hu SL.
J Virol.
2010;
84
(5):
2573-84
-
Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression.
Piantadosi A,
Panteleeff D, Blish CA, Baeten JM, Jaoko W, McClelland RS, Overbaugh J.
J Virol.
2009;
83
(19):
10269-74
-
Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1.
Blish CA,
Jalalian-Lechak Z, Rainwater S, Nguyen MA, Dogan OC, Overbaugh J.
J Virol.
2009;
83
(15):
7783-8
-
Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41.
Blish CA,
Nguyen MA, Overbaugh J.
PLoS Med.
2008;
5
(1):
e9
-
Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses.
Blish CA,
Dogan OC, Derby NR, Nguyen MA, Chohan B, Richardson BA, Overbaugh J.
J Virol.
2008;
82
(24):
12094-103
-
HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry.
Blish CA,
Nedellec R, Mandaliya K, Mosier DE, Overbaugh J.
AIDS.
2007;
21
(6):
693-702
-
Transmission of HIV-1 in the face of neutralizing antibodies.
Blish CA,
Blay WM, Haigwood NL, Overbaugh J.
Curr HIV Res.
2007;
5
(6):
578-87
-
Anergic CD8+ T cells can persist and function in vivo.
Blish CA,
Dillon SR, Farr AG, Fink PJ.
J Immunol.
1999;
163
(1):
155-64
-
Chronic modulation of the TCR repertoire in the lymphoid periphery.
Blish CA,
Gallay BJ, Turk GL, Kline KM, Wheat W, Fink PJ.
J Immunol.
1999;
162
(6):
3131-40
-
Loss of cell cycle controls in apoptotic lymphoblasts of the bursa of Fabricius.
Neiman PE,
Blish C, Heydt C, Loring G, Thomas SJ.
Mol Biol Cell.
1994;
5
(7):
763-72
Help